AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

UroGen Pharma Ltd.

$32.72 +$10.01 (+44.08%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$33.48
Day Range
$32.39$33.65
Year Range
$16.50$50.81
Market Cap
1.6B
AVG Volume
894.61K
Trailing/Forward PE
-16.53/11.49
PEG ratio
0.18
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
URGN Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2188.73M
26 Q1140.49M
25 Q4109.79M
25 Q396.52M
25 Q294.24M
25 Q191.87M
24 Q490.4M
24 Q389.36M
24 Q285.01M
24 Q184.3M
Net Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
URGN Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-97.64M
26 Q1-133.22M
25 Q4-153.49M
25 Q3-164.64M
25 Q2-154.97M
25 Q1-138.43M
24 Q4-126.87M
24 Q3-115.38M
24 Q2-113.58M
24 Q1-104.32M
Operating Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
URGN Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-66.65M
26 Q1-108.21M
25 Q4-124.86M
25 Q3-133.41M
25 Q2-123.56M
25 Q1-107.96M
24 Q4-96.78M
24 Q3-83.73M
24 Q2-79.69M
24 Q1-69.23M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: URGN

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

UroGen Pharma Ltd.
URGN
Stockpicker

Video analysis: URGN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: URGN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.